Johnson & Johnson is an international corporation that develops pharmaceutical, medical, and consumer packaged goods. The company engages in the manufacturing and selling of products in the health care sectors. The following table provides the financial data of the company. Please use ratio analysis to find out the liquidity ratios, activity performance, leverage usage and profitability of the company and make an overall detailed performance evaluation throughout the years. Please also employ Dupont analysis to make further comments

Table: Johnson & Johnson Inc. Financial Data (in millions)

Item/Year	2019	2018	2017	2016
Current Assets	45,274,000	46,033,000	43,088,000	65,032,000
Current Liabilities	35,964,000	31,230,000	30,537,000	26,287,000
Inventories	9,020,000	8,599,000	8,765,000	8,144,000
Cash	19,287,000	19,687,000	18,296,000	41,907,000
Receivables	14,481,000	14,098,000	13,490,000	11,699,000
Total Assets	157,728,000	152,954,000	157,303,000	141,208,000
Total Liabilities	98,257,000	93,202,000	97,143,000	70,790,000
Total Equity	59,471,000	59,752,000	60,160,000	70,418,000
Sales	82,059,000	81,581,000	76,450,000	71,890,000
Cost of Goods Sold	27,556,000	27,091,000	25,354,000	21,685,000
EBIT	20,970,000	21,175,000	19,122,000	21,165,000
Interest	318,000	1,005,000	934,000	726,000
Net Income	15,199,000	15,297,000	1,300,000	16,540,000